Compounds > amikacin
Page last updated: 2024-08-23

amikacin and rifapentine

amikacin has been researched along with rifapentine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cynamon, MH; Klemens, SP; Swenson, CE1
Bermudez, LE; Inderlied, CB; Wu, M; Young, LS1
Casal Román, M; González Requero, AI; Rodríguez López, F; Villalba Montoro, R1
Bermudez, LE; Wu, M; Young, LS1

Reviews

1 review(s) available for amikacin and rifapentine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for amikacin and rifapentine

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:6

    Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis

1992
Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:4

    Topics: Amikacin; Dose-Response Relationship, Drug; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium avium Complex; Rifampin; Time Factors

1992
[In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
    Enfermedades infecciosas y microbiologia clinica, 1989, Volume: 7, Issue:8

    Topics: Amikacin; Clofazimine; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Mycobacterium avium Complex; Rifampin; Roxithromycin

1989
Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.
    The Journal of infectious diseases, 1987, Volume: 156, Issue:3

    Topics: Amikacin; Cells, Cultured; Drug Interactions; Humans; Liposomes; Macrophages; Mycobacterium avium; Rifampin

1987